Naoki Kunii

A Phase I-II Study of α-Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer

Shinichiro Motohashi, Kaoru Nagato, Naoki Kunii et al. · The Journal of Immunology · 2009 · 226 citations

Immunology, Immunoediting, Pathology +17

Combination therapy of <i>in vitro</i>‐expanded natural killer T cells and α‐galactosylceramide‐pulsed antigen‐presenting cells in patients with recurrent head and neck carcinoma

Naoki Kunii, S. Horiguchi, Shinichiro Motohashi et al. · Cancer Science · 2009 · 181 citations · Full text

Cell Therapy, Immunology, Immunoediting +24

Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy

Kazuki Yamasaki, S. Horiguchi, Motoyoshi Kurosaki et al. · Clinical Immunology · 2010 · 178 citations

Radiation Oncology, Tumor Immunology, Cancer Immunosurveillance +11

Phase I study of α-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer

Tetsuro Uchida, S. Horiguchi, Yuriko Tanaka et al. · Cancer Immunology Immunotherapy · 2007 · 158 citations · Full text

Radiation Oncology, Cancer Immunosurveillance, Nasal Submucosa +15

The apelin/APJ system induces maturation of the tumor vasculature and improves the efficiency of immune therapy

Hiroyasu Kidoya, Naoki Kunii, Hisamichi Naito et al. · Oncogene · 2011 · 71 citations

Cancer Immunosurveillance, Immunology, Immunologic Mechanism +12